Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification and Validation of a Nine-Gene Amino Acid Metabolism-Related Risk Signature in HCC
Yajuan Zhao, Junli Zhang, Shuhan Wang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Comprehensive Metabolic Profiling and Genome-wide Analysis Reveal Therapeutic Modalities for Hepatocellular Carcinoma
Qi Feng, Jia Li, Zhuoran Qi, et al.
Research (2023) Vol. 6
Open Access | Times Cited: 31
Metabolic Reprogramming of HCC: A New Microenvironment for Immune Responses
Beatrice Foglia, Marc Beltrà, Salvatore Sutti, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7463-7463
Open Access | Times Cited: 31
A multi-omic analysis reveals that gamabufotalin exerts anti-hepatocellular carcinoma effects by regulating amino acid metabolism through targeting STAMBPL1
Piao Zheng, Die Xu, Yisi Cai, et al.
Phytomedicine (2024) Vol. 135, pp. 156094-156094
Closed Access | Times Cited: 14
Harnessing CD8+ T cell dynamics in hepatitis B virus‐associated liver diseases: Insights, therapies and future directions
Bing Yue, Yuxia Gao, Yi Hu, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 7
Open Access | Times Cited: 7
Crosstalk between Epigenetics and Metabolic Reprogramming in Metabolic Dysfunction-Associated Steatotic Liver Disease-Induced Hepatocellular Carcinoma: A New Sight
Anqi Li, Rui Wang, Yu-Qiang Zhao, et al.
Metabolites (2024) Vol. 14, Iss. 6, pp. 325-325
Open Access | Times Cited: 4
Integrative Analysis of DNA Methylation and microRNA Reveals GNPDA1 and SLC25A16 Related to Biopsychosocial Factors Among Taiwanese Women with a Family History of Breast Cancer
Sabiah Khairi, Chih‐Yang Wang, Gangga Anuraga, et al.
Journal of Personalized Medicine (2025) Vol. 15, Iss. 4, pp. 134-134
Open Access
Combining bulk and single-cell RNA-sequencing data to develop an NK cell-related prognostic signature for hepatocellular carcinoma based on an integrated machine learning framework
Qian Feng, Zhihao Huang, Lei Song, et al.
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 10
Effects of Lipid Metabolism-Related Genes PTGIS and HRASLS on Phenotype, Prognosis, and Tumor Immunity in Lung Squamous Cell Carcinoma
Kai Lei, Ruihao Liang, Binghua Tan, et al.
Oxidative Medicine and Cellular Longevity (2023) Vol. 2023, pp. 1-31
Open Access | Times Cited: 8
Amino acid metabolism-related genes as potential biomarkers and the role of MATN3 in stomach adenocarcinoma: A bioinformatics, mendelian randomization and experimental validation study
Wenjun Zhu, Min Fu, Qianxia Li, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113253-113253
Open Access | Times Cited: 3
Prognostic Significance of Amino Acid Metabolism-Related Genes in Prostate Cancer Retrieved by Machine Learning
Ivana Samaržija, Koraljka Gall‐Trošelj, Paško Konjevoda
Cancers (2023) Vol. 15, Iss. 4, pp. 1309-1309
Open Access | Times Cited: 8
Characterization of Salivary and Plasma Metabolites as Biomarkers for HCC: A Pilot Study
Courtney E. Hershberger, Roma Raj, Arshiya Mariam, et al.
Cancers (2023) Vol. 15, Iss. 18, pp. 4527-4527
Open Access | Times Cited: 7
HMGCS2 serves as a potential biomarker for inhibition of renal clear cell carcinoma growth
Huajie Mao, Runzhi Wang, Fengling Shao, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 7
SIMarker: Cellular similarity detection and its application to diagnosis and prognosis of liver cancer
Mengsha Tong, Shijie Luo, Lin Gu, et al.
Computers in Biology and Medicine (2024) Vol. 171, pp. 108113-108113
Closed Access | Times Cited: 2
A Prognostic Model for Colon Adenocarcinoma Patients Based on Ten Amino Acid Metabolism Related Genes
Yangzi Ren, Shangwen He, Siyang Feng, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 11
Amino Acid Metabolism-Related lncRNA Signature Predicts the Prognosis of Breast Cancer
Yinwei Dai, Zhi-kai Wen, Zhixuan Wu, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 10
Identifying a Novel Endoplasmic Reticulum-Related Prognostic Model for Hepatocellular Carcinomas
Fei Ding, Jinping Li, Yong Zhang, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-24
Open Access | Times Cited: 10
Impact of Exogenous Treatment with Histidine on Hepatocellular Carcinoma Cells
Yusun Park, Yeonju Han, Dongwoo Kim, et al.
Cancers (2022) Vol. 14, Iss. 5, pp. 1205-1205
Open Access | Times Cited: 9
Expression of GOT2 Is Epigenetically Regulated by DNA Methylation and Correlates with Immune Infiltrates in Clear-Cell Renal Cell Carcinoma
Wallax Augusto Silva Ferreira, Edivaldo Herculano Corrêa de Oliveira
Current Issues in Molecular Biology (2022) Vol. 44, Iss. 6, pp. 2472-2489
Open Access | Times Cited: 9
Novel amino acid metabolism‐related gene signature to predict prognosis in clear cell renal cell carcinoma
Xiaofeng Cheng, Wen Deng, Zhicheng Zhang, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 8
Identification of an amino acid metabolism-associated gene signature predicting the prognosis and immune therapy response of clear cell renal cell carcinoma
Fan Zhang, Junyu Lin, Daiwen Zhu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 8
SEPHS1: Its evolution, function and roles in development and diseases
Jeyoung Bang, Donghyun Kang, Jisu Jung, et al.
Archives of Biochemistry and Biophysics (2022) Vol. 730, pp. 109426-109426
Open Access | Times Cited: 8
Discovery of Novel 2-Oxoacetamide Derivatives as B3GAT3 Inhibitors for the Treatment of Hepatocellular Carcinoma
Hao Yin, Menghan Zhang, Congying Gu, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 13, pp. 10743-10773
Closed Access | Times Cited: 1
A novel amino acid metabolism-related gene risk signature for predicting prognosis in clear cell renal cell carcinoma
Jiaqi Su, Xi Tian, Zihao Zhang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 6
Application of biological big data and radiomics in hepatocellular carcinoma
Guoxu Fang, Jianhui Fan, Zongren Ding, et al.
iLiver (2023) Vol. 2, Iss. 1, pp. 41-49
Open Access | Times Cited: 3
Metabolism-related long non-coding RNA in the stomach cancer associated with 11 AMMLs predictive nomograms for OS in STAD
Wenjian Jin, Kongbo Ou, Yuanyuan Li, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top